BUSINESSBLOOMBERG
Europe Has Its Own Biotech Star as Argenx Soars on Trial Success
Europe is highlighted as having its own 'Biotech Star,' exemplified by Argenx's stock soaring following successful trials. Overall, the article notes that it has been a big week for biotech stocks on both sides of the Atlantic.
Related Signal
Adjacent reporting
- Argenx Soars on Latest Trial Success for Autoimmune Drug Vyvgart
- French biotech stock soars 31% after new data on experimental medicine
- STAT+: Legend Biotech emerged as a rare market winner
- AI frenzy sees these European stocks gain over 100% this year in blockbuster rally
- Europe invents the future. Now let’s scale it.